human | Q5 |
P269 | IdRef ID | 13845339X |
P213 | ISNI | 0000000431995450 |
P496 | ORCID iD | 0000-0002-0479-6291 |
P3829 | Publons author ID | 1703798 |
P1053 | ResearcherID | I-5059-2016 |
P214 | VIAF ID | 206188658 |
P69 | educated at | Bordeaux Segalen University | Q13340 |
University of Bordeaux | Q13344 | ||
McGovern Medical School | Q96418922 | ||
P735 | given name | Christophe | Q16274785 |
Christophe | Q16274785 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q34292415 | A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma |
Q28142236 | A mechanism for translationally coupled mRNA turnover: interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex |
Q34100430 | A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia |
Q54399532 | Analysis of post-transcriptional regulation using the FunREG method. |
Q39857515 | Analysis of post-transcriptional regulations by a functional, integrated, and quantitative method. |
Q72408162 | Colony-stimulating factors and cell cycle in the chemotherapy of acute myelogenous leukemia |
Q90375452 | Cytolethal distending toxin induces the formation of transient messenger-rich ribonucleoprotein nuclear invaginations in surviving cells |
Q43646242 | Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells. |
Q73883411 | Differential effect of interferon alpha on chronic myelogenous leukaemia and normal haematopoietic progenitors in a stromal cell co-culture context: role of the flt3 ligand |
Q73072421 | Flt3-ligand induces adhesion of haematopoietic progenitor cells via a very late antigen (VLA)-4- and VLA-5-dependent mechanism |
Q42479140 | In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. |
Q45108187 | In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. |
Q47262499 | In vivo studies of translational repression mediated by the granulocyte-macrophage colony-stimulating factor AU-rich element |
Q77768132 | Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis |
Q42469143 | Leukaemia inhibitory factor expression is inhibited by glucocorticoids through post-transcriptional mechanisms. |
Q51742707 | MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling. |
Q36932880 | MicroRNA-1291-mediated silencing of IRE1α enhances Glypican-3 expression. |
Q48274301 | New insights into diagnosis and therapeutic options for proliferative hepatoblastoma |
Q41093562 | New tumor suppressor microRNAs target glypican-3 in human liver cancer. |
Q33361212 | Platelet-associated CD154 in immune thrombocytopenic purpura |
Q44457834 | Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes. |
Q48219250 | Role of Glycanation and Convertase Maturation of Soluble Glypican-3 in Inhibiting Proliferation of Hepatocellular Carcinoma Cells. |
Q42127926 | SimBA: A methodology and tools for evaluating the performance of RNA-Seq bioinformatic pipelines |
Q39659945 | The ARE-associated factor AUF1 binds poly(A) in vitro in competition with PABP. |
Q90362559 | The Nuclear Remodeling Induced by Helicobacter Cytolethal Distending Toxin Involves MAFB Oncoprotein |
Q52319522 | Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression in vivo. |
Q71704241 | [Acute myeloid leukemias: role of growth factors to improve the efficacy of chemotherapy] |
Q93177319 | [MicroRNAs, small genic regulators with high therapeutic potential in oncology] |
Q81295159 | [Platelet-associated CD154: a new interface in haemostasis and in the inflammatory reaction] |
Q90709627 | miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation |
Search more.